/Tag: long acting melatonin

Physician’s Seal, LLC® Announces Data Analysis Plans for Ongoing Patient-Reported Outcomes (PRO) Studies Designed to Provide Confirmatory Real-World Evidence of Improvement in Sleep Duration and Sleep Quality for REMfresh®, the First and Only Continuous Release and Absorption Melatonin

Physician’s Seal, LLC® Announces Data Analysis Plans for Ongoing Patient-Reported Outcomes (PRO) Studies Designed to Provide Confirmatory Real-World Evidence of Improvement in Sleep Duration and Sleep Quality for REMfresh®, the First and Only Continuous Release and Absorption Melatonin Ongoing [...]

2019-05-14T08:36:58-07:00April 18th, 2019|0 Comments

Primary care sleep specialists broaden endorsement of clinically studied, non-prescription REMfresh®, a technological advance in sleep management, as both #1 recommended modified-release melatonin brand and #1 recommended melatonin brand overall.

Primary care sleep specialists broaden endorsement of clinically studied, non-prescription REMfresh®, a technological advance in sleep management, as both #1 recommended modified-release melatonin brand and #1 recommended melatonin brand overall. Drug-free, nonprescription REMfresh®, the first continuous release and absorption [...]

2019-04-24T05:41:06-07:00April 17th, 2019|0 Comments

REAL-WORLD DATA FROM SURVEILLANCE STUDY CONFIRMS EXCELLENT SAFETY AND TOLERABILITY PROFILE OF REMfresh® ION-POWERED MELATONIN™ AT 12 MONTHS

REAl-WORLD DATA FROM SURVEILLANCE STUDY CONFIRMS EXCELLENT SAFETY AND TOLERABILITY PROFILE OF REMfresh® ION-POWERED MELATONIN™ AT 12 MONTHS   REMfresh® Safety Update at 12 Months (REMSU-12) for REMfresh® reconfirms safety profile seen in REMSU-6. No serious adverse events for [...]

2019-04-24T05:42:03-07:00July 23rd, 2018|0 Comments

PATIENT-REPORTED OUTCOMES STUDY, PRESENTED AT SLEEP 2018, PROVIDES CONFIRMATORY REAL-WORLD EVIDENCE OF THE PREVIOUSLY PRESENTED 7-HOUR ACTION OF REMfresh®, THE FIRST CONTINUOUS RELEASE AND ABSORPTION MELATONIN™

PATIENT-REPORTED OUTCOMES STUDY, PRESENTED AT SLEEP 2018, PROVIDES CONFIRMATORY REAL-WORLD EVIDENCE OF THE PREVIOUSLY PRESENTED 7-HOUR ACTION OF REMfresh®, THE FIRST CONTINUOUS RELEASE AND ABSORPTION MELATONIN™    More than 77 percent of patients in the REMfresh® Patient Reported Outcomes [...]

2019-04-24T05:42:04-07:00June 6th, 2018|0 Comments